Market Overview

UPDATE: Jefferies Raises PT to $65 on CME Group on Long-Term Outlook

Share:
Related CME
CME Group's April Average Contracts Rise 21%
10 Stocks Moving In Friday's Pre-Market Session
The Vetr community has upgraded $CME to 4.5-Stars. (Vetr)

Jefferies reiterated its Buy rating on CME Group (NASDAQ: CME) and raised its price target from $60 to $65.

Jefferies noted, "Last week we spent several days with the management team of CME Group. The focus of the meetings centered around OTC clearing and execution initiatives and the globalization of CME's products, all of which represent potential offsets to the current lackluster environment for trading. On a longer-term basis we see several structural changes that should drive accelerating growth at CME."

CME Group closed at $57.29 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
May 2016Buckingham ResearchInitiates Coverage onBuy
Apr 2016Keefe Bruyette & WoodsMaintainsMarket Perform
Mar 2016JP MorganMaintainsNeutral

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

View Comments and Join the Discussion!